17122 Federal Register / Vol. 71, No.
65 / Wednesday, April 5, 2006 / Notices
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Molecular
Biology.
Date: May 22–24, 2006.
Time: 6 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Silver Spring, 8727 Colesville
Road, Silver Spring, MD 20910.
Contact Person: Michael B. Small, PhD,
Scientific Review Administrator, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Blvd., Room 8127, Bethesda, MD
20892–8328. 301–402–0996.
smallm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: March 29, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–3222 Filed 4–4–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), as amended.
The concept review and the discussions
wwhite on PROD1PC61 with NOTICES
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the concept review, the
VerDate Aug<31>2005 16:10 Apr 04, 2006 Jkt 208001
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, P4 Concept
Review.
Date: April 25, 2006.
Time: 8 a.m. to 2 p.m.
Agenda: To review and evaluate concept
review.
Place: Residence Inn Bethesda, 7335
Wisconsin Ave., Bethesda, MD 20814.
Contact Person: Timothy C. Meeker, PhD,
Scientific Review Administrator, Special
Review and Logistics Branch, National
Cancer Institute, 6116 Executive Boulevard,
Room 8103, Bethesda, MD 20892. 301–594–
1279, meekert@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support,
93.398, Cancer Research Manpower, 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: March 29, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–3223 Filed 4–4–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center on Minority Health and
Health Disparities; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center on
Minority Health and Health Disparities
Special Emphasis Panel, LRP for Health
Disparities & Extramural Clinical Research—
Panel B.
Date: April 24, 2006.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\05APN1.SGM
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Lorrita Watson, PhD.,
National Center on Minority Health, and
Health Disparities, National Institutes of
Health, 6707 Democracy Blvd., Suite 800,
Bethesda, MD 20892–5465. (301) 402–1366.
watsonl@ncmhd.nih.gov.
Name of Committee: National Center on
Minority Health and Health Disparities
Special Emphasis Panel, Loan Repayment
Program for Health Disparities Research—
Panel C.
Date: May 12, 2006.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Lorrita Watson, PhD.,
National Center on Minority Health, and
Health Disparities, National Institutes of
Health, 6707 Democracy Blvd., Suite 800,
Bethesda, MD 20892–5465. (301) 402–1366.
watsonl@ncmhd.nih.gov.
Dated: March 29, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–3224 Filed 4–4–06; 8:45am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Long-Term Oxygen Treatment Trial.
Date: April 12, 2006.
Time: 7 p.m. to 11 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
05APN1